ACCESS CHINA Spring Forum 2021 | China Out-Licensing Event
Hundreds of biopharma executives congregated for ACCESS CHINA to meet with the potential partners for development, licensing or commercial collaborations. The two-day conference agenda included company presentations and panel discussion.
Hundreds of biopharma executives congregated for ACCESS CHINA to meet with the potential partners for development, licensing or commercial collaborations. The two-day conference agenda included company presentations and panel discussion.
This conference is the first “CHINA Innovation” themed corporate access event. We selected 21 Chinese innovative pharma companies looking for global or regional out-licensing opportunities.
View all presenting companies here
Highlights of the meeting:
“China Biotech Innovation 50 Report” Release
Panel session: Preparing You and Your Firm for a Global Licensing Campaign
Presentation of 21 Chinese Biopharmas with 50 Innovative Assets
Thank you for joining us at ACCESS CHINA Spring Forum 2021 and we hope to see you at our next coming event in June.
Sincerely,
ACCESS CHINA Forum Organizing Committee
YAFO “China Biotech Innovation 50” Report Release
Cynthia Wang, Chairman of CHBD, giving the opening speech
Mr. Jin, BD Director of Shanghai Pharma, presenting their products
Tian Lu, Project Manager of JinXin Pharma, presenting their products
Panel session: Preparing You and Your Firm for a Global Licensing Campaign
Dennis Ford (Founder and CEO of LSN)
Kun Tao (Managing Partner of YAFO Capital)